Hepatitis B – Perinatal

Report within 24 hours of Diagnosis to the Local Health Department.

The New Jersey Department of Health, Vaccine Preventable Disease Program implemented the Perinatal Hepatitis B Prevention Program (PHBPP) in 1993. The primary goal is to identify all pregnant hepatitis B surface antigen (HBsAg) positive women to ensure prophylaxis of newborns at birth, completion of the hepatitis B virus (HBV) vaccine series, and post vaccination serology testing.  For nearly 20 years, the PHBPP has promoted the recommendations for the prevention of perinatal HBV, infection endorsed by the Advisory Committee on Immunization Practices of the Centers for Disease Control and prevention, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Congress of Obstetricians and Gynecologists.  The PHBPP depends on the cooperation of many public health and health care professionals throughout the state to succeed. Obstetricians, pediatricians, family practice physicians, birthing hospitals, hospital and commercial laboratories, local health departments and other health and social service agencies must work together to accomplish the following objectives:

  • Ensure all women are screened for HBsAg at each pregnancy and reported if positive
  • Ensure all infants born to HBsAg positive mothers are identified, reported, and receive timely immunoprophylaxis
  • Promote HBV vaccination for all infants


Return to the main viral hepatitis page

Education Materials
Disease Prevention
Perinatal Hepatitis B Webinars

Below is a list of the Perinatal Hepatitiis B Program (PHBPP) webinars to date. These webinars are meant to provide local health department staff and other interested parties information about the PHBPP including updates in recommendations and investigation tools.  


Last Reviewed: 2/13/2023